Similar to BRCA1 or BRCA2 deletion, copy number loss of each gene in the CK2–HTATSF1–TOPBP1 axis predicted higher HRD scores in TCGA breast tumors (Fig. 5B). This evidence concerns the gene HTATSF1 and breast neoplasm.